Friday, March 26, 2021 4:14:29 PM
If MDT owns 30% of the shares, they are still outstanding shares. They would effectively be paying themselves for those shares so they "get a refund" so to speak on the overall buyout price, but it does not discount the value of each share (including mine and yours)by 30%. It is still total buyout price divided by outstanding share count.
Message in reply to:
Everyone keeps valuing this robot with Medtronic like they don’t already own 30% of it. That will get subtracted off any BO offer. So again, $2 billion valuation minus 1/3 of IP already paid for by MDT comes down to $1.3 B and around nine bucks a share. Woo hoo.
If you were in the medical device industry and in hospitals you would realize that the intuitive SP robot makes up less than 5% of their capital and disposable business.
Robots that have sold for $3.5 B and up we’re robots that would handle the entire amount of indications for the procedures.
In other words, Auris doesn’t need a second robot to come in and handle the more complex indications. Same with the Mazor spine robot.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM